NSE › Healthcare

Laurus Labs Limited (LAURUSLABS)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,811.40-0.26%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹1,812 cr

Revenue YoY

+5.3%

Net profit

₹279 cr

Profit YoY

+19.5%

EPS

₹5.17

EPS estimate

₹4.98

Net margin

15.4%

EPS came in at 5.17 against a street estimate of 4.98 — a beat of 3.8%.

Key statistics

Market cap

₹98,067 cr

P/E

90.0

Forward P/E

0.0

P/B

18.52

Book value

₹98.17

EPS (TTM)

₹20.16

52-week high

₹1,838.30

52-week low

₹808.58

50-day MA

₹1,493.93

200-day MA

₹1,165.66

Beta

0.43

Analyst view

with an average price target of ₹1,486.29.

Shareholding

Promoters

32.04%

Institutions

30.49%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Laurus Labs Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited

Data updated 2026-08-05.